ASCO Measures Available for Use

In addition to clinical performance measures endorsed by the National Quality Forum (NQF) and/or implemented in federal programs, ASCO has measures that have been fully specified and are available for use. ASCO measures are copyrighted and commercial use of the measures requires a license. Commercial use is defined as the sale, licensure, or distribution of measures for commercial gain, or incorporation of the measure into a product or service that is sold, licensed, or distributed for commercial gain. If your organization is interested in licensing ASCO measures, please contact measurement@asco.org.

Measure Title Measure Type Care Domain Testing Status
Appropriate Antiemetic Therapy for High- and Moderate-Emetic-Risk Antineoplastic Agents eCQM Supportive Care Face validity performed 
Antiemetic Therapy for Low- and Minimal-Emetic-Risk Antineoplastic Agents – Avoidance of Overuse (Lower Score – Better) eCQM Supportive Care Face validity performed 
Conquer Cancer Grant: Dyspnea, Nausea/Vomiting and Performance Status Assessed at Every Telehealth Encounter for Patients with Metastatic Cancer eCQM Supportive Care In testing queue
Conquer Cancer Grant: Dyspnea, Nausea/Vomiting and Performance Status Assessed at Every Face-to-Face (In-Person) Encounter for Patients with Metastatic Cancer eCQM Supportive Care In testing queue
Conquer Cancer Grant: Telehealth Advance Directive Documentation for Patients with Metastatic Cancer eCQM  Supportive Care In testing queue
Conquer Cancer Grant: Hospice Referral or Enrollment/Palliative Care Referral or Services for Patients with Metastatic Cancer Not Receiving Telehealth Care eCQM  Supportive Care In testing queue
Conquer Cancer Grant: Hospice Referral or Enrollment/Palliative Care Referral or Services for Patients with Metastatic Cancer Receiving Telehealth Care eCQM Supportive Care In testing queue
Conquer Cancer Grant: Bowel Regimen Offered/Prescribed on a Telehealth Encounter eCQM Supportive Care In testing queue
Conquer Cancer Grant: Preventative Care and Screening: Screening for Depression on Telehealth Encounter eCQM  Supportive Care In testing queue
Conquer Cancer Grant: Oncology: Medical and Radiation-Pain Intensity Quantified on Telehealth Encounter eCQM  Supportive Care In testing queue

ASCO Measures in Development 

The measures below are currently under development by ASCO-led Technical Expert Panels (TEPs).  To learn about volunteer opportunities or to indicate interest in participating in measure development at ASCO, please visit https://volunteer.asco.org/opportunities

Measure Title Measure Type Care Domain
Appropriate Germline Testing for Ovarian Cancer Patients  eCQM Gynecologic oncology
BRAF Mutational Analysis Results Received for Patients Treated for Metastatic Colorectal Cancer eCQM Gastroinestinal
Appropriate Management of Immune-Related Hepatic Toxicity for Patients Receiving Immune-Checkpoint Inhibitors eCQM Immuno-oncology

Participation in ASCO Measure Testing 

ASCO measures with completed narrative specifications move into a measure testing queue. ASCO periodically recruits practices to participate in feasibility, reliability, and validity testing, and FASCO points and stipends are available depending on the type of testing performed. To express interest in participating in measure testing, please contact us at measurement@asco.org.

2022 Planned Measure Testing 

Measure Title Measure Type Testing Type
BRAF Mutational Analysis Results Received for Patients Treated for Metastatic Colorectal Cancer eCQM Validity, Reliability
Appropriate Germline Testing for Ovarian Cancer Patients eCQM/CQM Validity, Reliability
Pain Intensity Quantified  eCQM Validity, Reliability